Anti-LMAN2L monoclonal antibody

Pre-made anti-LMAN2L monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LMAN2L/LMAN2L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1092-Ab-1/ GM-Tg-hg-IP1092-Ab-2Anti-Human LMAN2L monoclonal antibodyHuman
GM-Tg-rg-IP1092-Ab-1/ GM-Tg-rg-IP1092-Ab-2Anti-Rat LMAN2L monoclonal antibodyRat
GM-Tg-mg-IP1092-Ab-1/ GM-Tg-mg-IP1092-Ab-2Anti-Mouse LMAN2L monoclonal antibodyMouse
GM-Tg-cynog-IP1092-Ab-1/ GM-Tg-cynog-IP1092-Ab-2Anti-Cynomolgus/ Rhesus macaque LMAN2L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1092-Ab-1/ GM-Tg-felg-IP1092-Ab-2Anti-Feline LMAN2L monoclonal antibodyFeline
GM-Tg-cang-IP1092-Ab-1/ GM-Tg-cang-IP1092-Ab-2Anti-Canine LMAN2L monoclonal antibodyCanine
GM-Tg-bovg-IP1092-Ab-1/ GM-Tg-bovg-IP1092-Ab-2Anti-Bovine LMAN2L monoclonal antibodyBovine
GM-Tg-equg-IP1092-Ab-1/ GM-Tg-equg-IP1092-Ab-2Anti-Equine LMAN2L monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1092-Ab-1/ GM-Tg-hg-IP1092-Ab-2; GM-Tg-rg-IP1092-Ab-1/ GM-Tg-rg-IP1092-Ab-2;
GM-Tg-mg-IP1092-Ab-1/ GM-Tg-mg-IP1092-Ab-2; GM-Tg-cynog-IP1092-Ab-1/ GM-Tg-cynog-IP1092-Ab-2;
GM-Tg-felg-IP1092-Ab-1/ GM-Tg-felg-IP1092-Ab-2; GM-Tg-cang-IP1092-Ab-1/ GM-Tg-cang-IP1092-Ab-2;
GM-Tg-bovg-IP1092-Ab-1/ GM-Tg-bovg-IP1092-Ab-2; GM-Tg-equg-IP1092-Ab-1/ GM-Tg-equg-IP1092-Ab-2
Products NameAnti-LMAN2L monoclonal antibody
Formatmab
Target NameLMAN2L
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LMAN2L monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1092-Ag-1Recombinant multi-species LMA2L/ LMAN2L/ MRT52 protein


    Target information

    Target IDGM-IP1092
    Target NameLMAN2L
    Gene ID81562,214895,301343,706379,474569,101091780,539289,100051330
    Gene Symbol and SynonymsA630028F14Rik,LMAN2L,MRD69,MRT52,VIP36-like,VIPL
    Uniprot AccessionQ9H0V9,Q2HJD1
    Uniprot Entry NameLMA2L_HUMAN,LMA2L_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000114988
    Target ClassificationN/A

    The target: LMAN2L, gene name: LMAN2L, also named as MRT52, VIPL. This gene encodes a protein belonging to the L-type lectin group of type 1 membrane proteins, which function in the mammalian early secretory pathway. These proteins contain luminal carbohydrate recognition domains, which display homology to leguminous lectins. Unlike other proteins of the group, which cycle in the early secretory pathway and are predominantly associated with post endoplasmic reticulum membranes, the protein encoded by this gene is a non-cycling resident protein of the ER, where it functions as a cargo receptor for glycoproteins. It is proposed to regulate exchange of folded proteins for transport to the Golgi and exchange of misfolded glycoproteins for transport to the ubiquitin-proteasome pathway. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.